drugset / Trial / NCT07187258

the Use of Tranexamic Acid to Prevent the Bleeding in Bariatric Surgery

NCT07187258 ↗

Phase 4 Completed 132 enrolled Cairo University
RandomizedParallel-groupDouble-blindPrevention

Summary

Our study aims at evaluating the role of tranexamic acid in bariatric surgery since, The effect of conservative therapy using tranexamic acid for postoperative hemorrhage after bariatric surgery is still very much a novel technique. However,Intravenous tranexamic acid at the time of laparoscopic sleeve gastrectomy is associated with a significant reduction of post-operative bleeding with no observed differences in thromboembolic events or mortality.

Timeline

Start
2024-07-01
Primary completion
2025-07-01
Completion
2025-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications